Targeted KRAS(G12V) degradation elicits efficient and durable lung adenocarcinoma regression in vivo
Alberto Martín, Inés María García-Pérez, Sonia San José, Pep Rojo, Carlos Riego‐Mejías, Cristina Teodósio, Bárbara M. G. Barbosa, Carolina Sánchez, Ignasi Folch-I-Casanovas, María Antonia Odena, Sònia Jarió, Sara Hijazo‐Pechero, Silvia M. Rodríguez-López, Rodrigo Entrialgo‐Cadierno, Marie‐Julie Nokin, , Cristina Mayor‐Ruiz
This study shows that targeted KRAS(G12V) degradation causes durable lung adenocarcinoma regression in mice, with tumor relapse linked to proteolysis machinery dysregulation.
Cancer Research · May 27, 2026Peer-reviewedCancer Biology